Compared with developed economies, health expenditure in China is not particularly high on a per capita basis or as a … high on a per capita basis or as a percentage of GDP. China's exceptionally high rate of pharmaceutical expenditure has … priority for China's health policymakers. Several factors are discussed for reforming this system based on lessons from recent …

This paper examines the financing, pricing, and utilization of pharmaceuticals in China the pharmaceutical system as it … paper builds upon earlier critical reviews and other papers published in the series china health policy notes. The paper is …; China's position in the global market; and size, composition, and trends in the domestic market. The second section examines …

different stages of development from a geographic approach in the case of China. It aims at offering empirical supports on (1 …

been a challenge, with manufacturing mostly concentrated in the US and Europe for high-value mRNA vaccines, and China and …

challenge, with manufacturing mostly concentrated in the US and Europe for high-value mRNA vaccines, and China and India for …